Chinese Hepatolgy ›› 2021, Vol. 26 ›› Issue (10): 1057-1068.
• Guideline and Consensus • Next Articles
Liver Cancer Study Group,Chinese Society of Hepatology,Chinese Medical Association
Received:
Online:
Published:
Abstract: With the development of anti-HBV and HCV therapy,experts in related fields organized by the Liver Cancer Study Group,Chinese Society of Hepatology,Chinese Medical Association updated “Experts Consensus on Antiviral Therapy for HBV/ HCV-related Hepato-cellular Carcinoma”.On the basis of previous expert recommendations/ consensus and the new evidence in recent years,this new consensus was developed,and the relevant recommendations are provided to hepatologists,epidemiologists,medical doctors and specialists working in community service centers and primary health care institutions for guidance of hepatocellular carcinoma antiviral treatment.
Key words: Hepatitis B Virus, Hepatitis C Virus, Hepatocellular Carcinoma, Therapeutics, Consensus
Liver Cancer Study Group,Chinese Society of Hepatology,Chinese Medical Association. Expert consensus on antiviral therapy for HBV/HCV-related hepatocellular carcinoma:A 2021 update[J]. Chinese Hepatolgy, 2021, 26(10): 1057-1068.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.hepatoday.org/EN/
http://www.hepatoday.org/EN/Y2021/V26/I10/1057